Merck: Aggressive M&A Efforts To Prepare For A Keytruda Patent Cliff (NYSE:MRK)

If you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Towards the end of the first quarter, Merck ( MRK ) announced a larger acquisition to ignite some appeal in its pipeline. This was the second-largest deal announced in recent times, as Merck is sp ...